Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-10 7:00 pm Purchase |
2025-03-06 | 13D | Oruka Therapeutics, Inc. ORKA |
Fairmount Funds Management LLC | 8,511,824 19.990% |
570,134 (+7.18%) |
Filing History |
| 2025-02-14 3:45 pm Purchase |
2024-12-31 | 13G | Inhibikase Therapeutics, Inc. IKT |
Fairmount Funds Management LLC | 7,018,575 9.900% |
398,264 (+6.02%) |
Filing History |
| 2025-02-14 3:45 pm Unchanged |
2024-12-31 | 13G | Enliven Therapeutics, Inc. ELVN |
Fairmount Funds Management LLC | 3,202,798 6.600% |
0 (Unchanged) |
Filing History |
| 2025-02-14 3:45 pm Purchase |
2024-12-31 | 13G | Astria Therapeutics, Inc. ATXS |
Fairmount Funds Management LLC | 5,869,037 9.900% |
992 (+0.02%) |
Filing History |
| 2025-02-14 3:45 pm Sale |
2024-12-31 | 13G | AnaptysBio, Inc. ANAB |
Fairmount Funds Management LLC | 0 0.000% |
-1,671,484 (Position Closed) |
Filing History |
| 2025-02-14 3:45 pm Sale |
2024-12-31 | 13G | Kiniksa Pharmaceuticals, Ltd. KNSA |
Fairmount Funds Management LLC | 0 0.000% |
-3,204,841 (Position Closed) |
Filing History |
| 2024-12-18 4:30 pm Purchase |
2024-12-11 | 13G | AnaptysBio, Inc. ANAB |
Fairmount Funds Management LLC | 1,671,484 5.500% |
1,671,484 (New Position) |
Filing History |
| 2024-11-21 6:30 pm Purchase |
2024-11-19 | 13D | Oruka Therapeutics, Inc. ORKA |
Fairmount Funds Management LLC | 7,941,690 19.990% |
17 (+0.00%) |
Filing History |
| 2024-11-14 4:15 pm Sale |
2024-09-30 | 13G | Terns Pharmaceuticals, Inc. TERN |
Fairmount Funds Management LLC | 0 0.000% |
-6,632,015 (Position Closed) |
Filing History |
| 2024-11-14 4:15 pm Purchase |
2024-09-30 | 13G | Kiniksa Pharmaceuticals, Ltd. KNSA |
Fairmount Funds Management LLC | 3,204,841 7.900% |
3,204,841 (New Position) |
Filing History |
| 2024-11-14 4:15 pm Purchase |
2024-09-30 | 13G | Astria Therapeutics, Inc. ATXS |
Fairmount Funds Management LLC | 5,868,045 9.900% |
2,234,080 (+61.48%) |
Filing History |
| 2024-11-14 4:15 pm Purchase |
2024-09-30 | 13G | Enliven Therapeutics, Inc. ELVN |
Fairmount Funds Management LLC | 3,202,798 6.800% |
1,071,429 (+50.27%) |
Filing History |
| 2024-10-17 7:00 pm Purchase |
2024-10-09 | 13G | Inhibikase Therapeutics, Inc. IKT |
Fairmount Funds Management LLC | 6,620,311 9.900% |
6,620,311 (New Position) |
Filing History |
| 2024-09-17 9:00 pm Purchase |
2024-09-13 | 13D | Viridian Therapeutics, Inc. VRDN |
Fairmount Funds Management LLC | 15,556,685 17.950% |
1,600,000 (+11.46%) |
Filing History |
| 2024-09-13 4:57 pm Purchase |
2024-09-11 | 13D | Oruka Therapeutics, Inc. ORKA |
Fairmount Funds Management LLC | 7,941,673 19.990% |
1,330,418 (+20.12%) |
Filing History |
| 2024-09-06 5:08 pm Purchase |
2024-08-29 | 13D | Oruka Therapeutics, Inc. ORKA |
Fairmount Funds Management LLC | 6,611,255 19.990% |
6,611,255 (New Position) |
Filing History |
| 2024-06-13 06:06 am Purchase |
2024-06-11 | 13D | Cogent Biosciences, Inc. COGT |
Fairmount Funds Management LLC | 11,330,141 9.900% |
1,343,585 (+13.45%) |
Filing History |
| 2024-04-25 4:40 pm Purchase |
2024-04-23 | 13D | Spyre Therapeutics, Inc. SYRE |
Fairmount Funds Management LLC | 4,508,579 11.170% |
3,672,120 (+439.01%) |
Filing History |
| 2024-04-01 6:38 pm Unchanged |
2024-03-28 | 13D | Viridian Therapeutics, Inc. VRDN |
Fairmount Funds Management LLC | 13,956,685 18.640% |
0 (Unchanged) |
Filing History |
| 2024-04-01 6:34 pm Sale |
2024-04-01 | 13D | Dianthus Therapeutics, Inc. DNTH |
Fairmount Funds Management LLC | 2,957,385 9.990% |
-3,362 (-0.11%) |
Filing History |